Search results for "Estrogen"

showing 10 items of 530 documents

High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast can…

2021

Oestrogen receptor (ER)-negative (–) progesterone receptor (PgR)-positive (+) is the least common combination of steroid receptor expression observed in breast cancer. There are many controversies regarding the actual existence of ER–/PgR+ phenotype. In the current study, we aimed to perform comprehensive immunohistochemical re-evaluation of ER–/PgR+ breast cancers from multiple institutions. A total of 135 cases of ER–/PgR+ breast cancer were collected from 11 institutions from the period 2006–2020 and subsequently stained with three clinically validated anti-ER antibody clones: SP1 (Roche), 1D5 (Dako), and EP1 (Dako), and two anti-PgR antibody clones: 636 (Dako), and 1E2 (Roche). Clinicop…

breast cancerReceptors EstrogenOestrogen receptorReceptor ErbB-2immunohistochemistryHumansBreast NeoplasmsFemaleprognosisReceptors Progesteroneprogesterone receptorPathology and Forensic MedicinePathology
researchProduct

Endometrial Adenocarcinoma in Syrian Hamsters Treated with Diethylstilbestrol, Tamoxifen and N-Ethyl-Nitrosourea

2006

The synthetic estrogen diethylstilbestrol (DES) causes marked abnormalities in the female hamster genital tract, after either prenatal or postnatal exposure, leading to endometrial hyperplasia and carcinoma. Acting as an initiating event, DES altering uterine development may facilitate the abnormal response of promoting agents. Tamoxifen (TAM) is an antiestrogen that competes for central and peripheral estrogen receptor (ERα). TAM exerts agonistic effects on E-dependent endometrial proliferation. N-ethyl-N-nitrosourea (ENU), a potent mutagenic agent, induces tumors in a variety of organs, predominantly in the peripheral nervous system. To test whether ENU and TAM treatment in a model of hyp…

business.industryDiethylstilbestrolEstrogen receptorHamsterAntiestrogenHyperestrogenismmedicine.diseaseEndometriumEndometrial hyperplasiamedicine.anatomical_structuremedicineCancer researchmedicine.symptomskin and connective tissue diseasesbusinesshormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drug
researchProduct

Modulators of Endogenous Neuroprotection: Estrogen, Corticotropin-releasing Hormone and Endocannabinoids

2005

Age-associated neurodegenerative disorders are among the most challenging problems of our aging society. Alzheimer’s disease is affecting people with increasing frequency, since there is a clear relationship between the incidence of this detrimental disorder and age. Other neurodegenerative disorders, including Parkinson’s disease, stroke and amyotrophic lateral sclerosis, are also frequently observed in our aging society. For most of these diseases, no causal therapy has yet been identified. Many of the treatments given to patients that are affected by these disorders have different side effects, and therefore the search is on to identify novel molecular approaches that may lead to a more …

business.industrymedicine.drug_classCentral nervous systemEstrogen receptorDiseaseNeuroprotectionEndocannabinoid systemCorticotropin-releasing hormonemedicine.anatomical_structureEstrogenmedicinebusinessCAMP response element bindingNeuroscience
researchProduct

Estrogens and Stem Cells in Thyroid Cancer

2014

Recent discoveries highlight the emerging role of estrogens in the initiation and progression of different malignancies through their interaction with stem cell compartment. Estrogens play a relevant role especially for those tumors bearing a gender disparity in incidence and aggressiveness, as occurs for most thyroid diseases. Although several experimental lines suggest that estrogens promote thyroid cell proliferation and invasion, their precise contribution in stem cell compartment still remains unclear. This review underlines the interplay between hormones and thyroid function, which could help to complete the puzzle of gender discrepancy in thyroid malignancies. Defining the associatio…

cancer stem cellsendocrine systemendocrine system diseasesMini ReviewEndocrinology Diabetes and MetabolismEstrogen receptorlcsh:Diseases of the endocrine glands. Clinical endocrinologyEndocrinologyCancer stem cellstem cellsgrowth factorsmedicinethyroid cancerThyroid cancerSettore MED/04 - Patologia Generalecancer stem cells (CSC)thyroid hormoneslcsh:RC648-665business.industryThyroidmedicine.diseasethyroid cancer stem cells cancer stem cells estrogens thyroid hormones growth factorsmedicine.anatomical_structureImmunologyCancer researchSignal transductionStem cellThyroid functionbusinessHormoneestrogensFrontiers in Endocrinology
researchProduct

Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.

2021

Abstract Objective Tissue factor pathway inhibitor (TFPI) is a potent anticoagulant protein in the extrinsic coagulation pathway. In the present study, we aim to identify the cardiovascular determinants for total TFPI activity and its association with cardiovascular disease (CVD) and total mortality. Methods Total TFPI activity was assessed in a selection of the population-based Gutenberg Health Study (n = 5,000). Statistical analysis was performed to identify the determinants for total TFPI activity as well as the associations with CVD and mortality. Results Multivariable linear regression analysis identified smoking (β 0.095 [0.054–0.136]) as a positive determinant for total TFPI activity…

cardiovascular risk factorsAdultMalemedicine.medical_specialtyLipoproteinsPopulationpopulationCoronary Artery DiseaseTFPICoronary artery diseaseTissue factor pathway inhibitorDiabetes mellitusInternal medicinemedicineDiabetes MellitusHumansObesityProspective StudieseducationAgededucation.field_of_studyVENOUS THROMBOEMBOLISMbiologyPLASMAProportional hazards modelbusiness.industrySmokingFactor VWOMENHematologyMiddle Agedmedicine.diseaseObesitymortalitytotal TFPI activityESTROGENEndocrinologyMYOCARDIAL-INFARCTIONFACTOR-VCardiovascular DiseasesHeart Disease Risk Factorsbiology.proteinPopulation studyepidemiologyFemalebusinessThrombosis and haemostasis
researchProduct

Resveratrol: distribución, propiedades y perspectivas

2013

Resveratrol is a natural polyphenol which can be found in many plants and fruits, such as peanuts, mulberries, blueberries and, above all, in grapes and red wine. Its synthesis is regulated by the presence of stressful factors, such as fungal contamination and ultra-violet radiation. In plants, it plays a role as a phytoalexin, showing a capacity to inhibit the development of certain infections. Plant extracts which contain resveratrol have been employed by traditional medicine for more than 2000 years. Resveratrol was first isolated, and its properties were initially studied with scientific methods, thirty years ago. Its in vitro properties have been extensively studied and demonstrated. I…

chemistry.chemical_classificationAgingPhytoalexinfood and beveragesMedicine (miscellaneous)ResveratrolPharmacologyIn vitroBioavailabilitychemistry.chemical_compoundMetabolic pathwaychemistryIn vivoPolyphenolPhytoestrogensGeriatrics and GerontologyRevista Española de Geriatría y Gerontología
researchProduct

Sex Differences in Mitochondrial Antioxidant Gene Expression

2020

Females live longer than males. This could be in part due to the higher levels of estrogens in females, which protect them against aging. Physiological concentrations of estrogens have antioxidant effects as they induce the expression of manganese superoxide dismutase and glutathione peroxidase by stimulating estrogen receptors and the mitogen-activated protein kinase and nuclear factor kappa B pathways. However, estrogens can have undesirable effects such as they are feminizing to males, so other alternatives need to be searched. Phytoestrogens are good candidates as they can also bind to estrogens receptors, and in fact, they are able to mimic the antioxidant properties of estrogens. It i…

chemistry.chemical_classificationmedicine.medical_specialtyAntioxidantmedicine.medical_treatmentGlutathione peroxidaseEstrogen receptorBiologyManganese Superoxide Dismutasechemistry.chemical_compoundEndocrinologychemistryInternal medicineGene expressionmedicinePhytoestrogensProtein kinase AReceptorhormones hormone substitutes and hormone antagonists
researchProduct

Phytoestrogens Up-regulate Antioxidant Genes

2009

chemistry.chemical_compoundAntioxidantchemistryBiochemistrymedicine.medical_treatmentmedicinePhytoestrogensBiologyGene
researchProduct

Sex Hormones and Healthy Psychological Aging in Women

2018

Besides their key role in reproduction, estrogens have effects in several organs in the body, as confirmed by the identification of estrogen receptors (ER) in multiple tissues. Experimental evidence has shown that estrogens have significant impacts on the central nervous system (CNS), and a key question is to what extent the fall in estrogen levels in the blood that occurs with increasing age, particularly around and following the menopause, has an impact on the cognitive function and psychological health of women, specifically regarding mood. This review will consider direct effects of menopausal changes in estrogens on the brain, including cognitive function and mood. Secondary pathways w…

cognitionAgingmedicine.drug_classCognitive Neurosciencemedicine.medical_treatmentmoodCentral nervous systemPhysiologyEstrogen receptorReviewsex hormoneslcsh:RC321-57103 medical and health sciences0302 clinical medicinemedicinepsychological aging030212 general & internal medicinelcsh:Neurosciences. Biological psychiatry. Neuropsychiatrybusiness.industryCognitionmedicine.diseaseMenopausemedicine.anatomical_structureMoodEstrogenHormone therapywomenbusiness030217 neurology & neurosurgeryHormoneNeuroscienceFrontiers in Aging Neuroscience
researchProduct

The Female Handball Player

2018

Female hormones fluctuate in concentrations during the menstrual cycle. This has triggered speculations among athletes, coaches, as well as researchers about the hormonal changes that lead to variations in athletic performance and adaptation to training. Many athletes, as in the general population, use oral contraceptives. This has raised questions concerning the suppression of the endogenous circulating female hormones and if the administration of synthetic hormones may have negative impact on athletic performance and training adaptations – or the opposite.

education.field_of_studybiologymedicine.drug_classAthletesbusiness.industrySports sciencemedia_common.quotation_subjectPopulationbiology.organism_classificationKnee laxityEstrogenmedicinebusinesseducationMenstrual cycleHormoneClinical psychologymedia_common
researchProduct